Compare GeneDx Holdings Corp (WGS) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GeneDx Holdings Corp vs Williams Companies Inc — how do they compare? GeneDx Holdings Corp trades at $86.53 (market cap $2.58B), while Williams Companies Inc trades at $75.31 (market cap $91.92B). The key difference: Williams Companies Inc is far larger — about 35.6× GeneDx Holdings Corp's market cap, and Williams Companies Inc pays a 2.79% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| WGS | WMB | |
|---|---|---|
Market Cap | $2.58B | $91.92B |
Sector | Technology | Energy |
52-Week High | $167.51 | $79.40 |
52-Week Low | $34.51 | $56.51 |
Enterprise Value | $2.61B | $122.55B |
Dividend Yield | — | 2.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
WGS trades at $85.87, down 0.14% today, with a bullish technical signal from moving averages and support at $84. The company reported Q2 2026 revenue of $114.4M, beating estimates, and returned to adjusted profitability early. However, net income remains negative at -$106M for 2026, with high valuation multiples like EV/EBITDA of 161.17. Recent news highlights partnerships and product launches, such as the NPC GenomeComplete initiative with Beren Therapeutics.
Outlook is mixed: strong analyst buy consensus (90.9%) and institutional interest support upside, but profitability challenges and a class action lawsuit pose risks. Revenue growth and operational improvements are key catalysts, yet high debt-to-asset ratios and negative margins require monitoring for sustained recovery.
WMB trades at $75.83, up 2.27% today, with a bullish technical outlook supported by moving averages and strong analyst consensus. The company reported mixed Q2 2026 earnings but maintains robust profitability with a 25.18% net income margin. Recent developments include the $5.5 billion acquisition of Momentum Midstream, enhancing its natural gas infrastructure, while a court ruling vacated a key permit for the NESE pipeline project.
The stock offers growth exposure to natural gas demand driven by LNG exports and AI infrastructure, with a consensus price target of $88.14 implying 16% upside. Risks include regulatory hurdles for pipeline projects and high debt levels, but strong cash flow supports dividends and expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
